Contradictory information about Zyban from the NIH

May 4, 2016

A classic example of one hand not knowing the other or the perils of partial information.  In Resources you will find 2 papers from NIH.  The first recommends bupropion (Zyban) for use in depression because of lack of weight gain when tested against fluoxetine and sertraline.  The 2nd paper is patient information from Medline Plus and warns against the risks of taking bupropion both for smoking control and for depression! More mind boggling, read for yourself


Leave a Comment